Guardian Capital LP on March 4 debuted its Guardian i 3 Global Dividend Premium Yield Fund and ETF (TSX: GIDY). The invests primarily in global dividend-paying securities and uses a dynamic ...

Obsidian Therapeutics, a specialist in tumour-infiltrating lymphocyte (TIL) cell therapies, has raised $160.5 million in a third-round financing round that will be used to fund its clinical ...

Davis Global Fund posted a strong return of +22.70% in 2024, substantially outperforming its MSCI ACWI (All Country World ...

Equity Fund Cl (TGF120.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Ficerafusp, an EGFR x TGF-beta bispecific, is currently in a Phase 2/3 trial for the treatment of head and neck squamous cell carcinoma (HNSCC). The analyst expressed confidence in the drug’s ...

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion ... Premium access to members-only fund manager video interviews • Ad-Free Browsing: Enjoy a year of ...

Ron Zibelli and Justin Livengood were added as managers of Invesco Global Opportunities. They will manage the US portion of the portfolio. As of Dec. 31, 2024, roughly 60% of the fund's stock ...

Putnam Global Technology Fund earns a Below Average Process Pillar rating. The process is strengthened by the fund's strong long-term risk-adjusted performance. This can be seen in its five-year ...

Watch the online edition of Global News Hour at 6 BC. Len Saunders, an immigration lawyer in Blaine, told Global News that he is not Mooney’s lawyer but he did speak to her a few weeks ago after ...

Learn about our editorial policies Every time you invest in a mutual fund, you're making a choice that could cost or save you tens of thousands of dollars—and you might not even know it.